AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2018
Feb 23, 2018
29821_dirs_2018-02-23_954fe737-165f-42a4-96d6-8dfe660d1218.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2018-02-21
Reporting Person: Pierce David A (SVP,Pres Urology,Pelvic Health)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-02-21 | Common Stock | S | 16286.0000 | $27.0000 | Disposed | 24201.0000 | Direct |
| 2018-02-22 | Common Stock | M | 2607.0000 | $0.0000 | Acquired | 26808.0000 | Direct |
| 2018-02-22 | Common Stock | F | 1159.0000 | $26.4800 | Disposed | 25649.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-02-22 | Deferred Stock Units | $ | M | 2607.0000 | Disposed | 2021-02-22 | Common Stock (2607.0000) | Direct |
Footnotes
F1: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2: Represents the weighted average sale price. These shares were sold in multiple transactions at $27.00 and $27.005. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F4: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.